Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.24B |
| 2 |
Apple
AAPL
|
+$939M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$714M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$673M |
| 5 |
Alibaba
BABA
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.45B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$653M |
| 3 |
GE Aerospace
GE
|
+$501M |
| 4 |
S&P Global
SPGI
|
+$439M |
| 5 |
SPDR Gold Trust
GLD
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.97% |
| 2 | Financials | 10.16% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Healthcare | 7.74% |
| 5 | Communication Services | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Varonis Systems
VRNS
$4.87B
| $4.11M | ﹤0.01% |
253,959
+4,026
| +2% | +$63.1K |
|
|
GTS
3277
DELISTED
Triple-S Management Corporation
GTS
| $4.1M | ﹤0.01% |
173,587
+29,578
| +21% | +$721K |
|
|
GHDX
3278
DELISTED
Genomic Health, Inc.
GHDX
| $4.1M | ﹤0.01% |
119,823
-15,742
| -12% | -$502K |
|
3279
Marten Transport
MRTN
$1.2B
| $4.1M | ﹤0.01% |
302,699
-76,024
| -20% | -$995K |
|
|
NCI
3280
DELISTED
Navigant Consulting, Inc.
NCI
| $4.09M | ﹤0.01% |
210,692
+17,556
| +9% | +$319K |
|
|
EOI
3281
Eaton Vance Enhanced Equity Income Fund
EOI
$828M
| $4.09M | ﹤0.01% |
281,727
+112,231
| +66% | +$1.6M |
|
|
MB
3282
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $4.08M | ﹤0.01% |
134,147
+57,403
| +75% | +$1.77M |
|
3283
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
| $4.08M | ﹤0.01% |
75,752
-1,057
| -1% | -$57.7K |
|
|
IBMK
3284
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
| $4.08M | ﹤0.01% |
158,809
+16,483
| +12% | +$427K |
|
3285
Invesco Bond Fund
VBF
$168M
| $4.07M | ﹤0.01% |
204,396
+3,225
| +2% | +$63.8K |
|
|
GPMT
3286
Granite Point Mortgage Trust
GPMT
$59.8M
| $4.06M | ﹤0.01% |
229,107
+164,560
| +255% | +$2.99M |
|
3287
Sprott Physical Silver Trust
PSLV
$13.7B
| $4.06M | ﹤0.01% |
640,744
-272,401
| -30% | -$1.71M |
|
|
AGN.PRA
3288
DELISTED
Allergan plc
AGN.PRA
| $4.06M | ﹤0.01% |
6,924
-8,639
| -56% | -$5.57M |
|
3289
Lindsay Corp
LNN
$1.17B
| $4.05M | ﹤0.01% |
45,882
+19,460
| +74% | +$1.77M |
|
3290
State Street SPDR S&P 1500 Momentum Tilt ETF
MMTM
$163M
| $4.03M | ﹤0.01% |
35,086
+1,024
| +3% | +$114K |
|
3291
Adtran
ADTN
$622M
| $4.03M | ﹤0.01% |
208,067
+109,727
| +112% | +$2.44M |
|
|
MIN
3292
Aberdeen Intermediate Income Fund
MIN
$278M
| $4.02M | ﹤0.01% |
968,698
-343,844
| -26% | -$1.44M |
|
3293
Modine Manufacturing
MOD
$10.1B
| $4.01M | ﹤0.01% |
198,469
+62,829
| +46% | +$1.35M |
|
|
EOT
3294
Eaton Vance National Municipal Opportunities Trust
EOT
$272M
| $4M | ﹤0.01% |
177,588
+13,352
| +8% | +$302K |
|
3295
Repligen
RGEN
$9.21B
| $3.99M | ﹤0.01% |
110,076
+39,121
| +55% | +$1.42M |
|
3296
TriCo Bancshares
TCBK
$1.82B
| $3.99M | ﹤0.01% |
105,436
-46,459
| -31% | -$1.91M |
|
|
BEAT
3297
DELISTED
BioTelemetry, Inc.
BEAT
| $3.99M | ﹤0.01% |
133,531
+48,701
| +57% | +$1.41M |
|
3298
Cass Information Systems
CASS
$734M
| $3.98M | ﹤0.01% |
82,087
+33,594
| +69% | +$1.68M |
|
3299
S&T Bancorp
STBA
$1.79B
| $3.98M | ﹤0.01% |
99,993
+8,100
| +9% | +$328K |
|
3300
Corbus Pharmaceuticals
CRBP
$177M
| $3.98M | ﹤0.01% |
18,663
+15,445
| +480% | +$3.31M |
|
Similar funds
Morgan Stanley's Q4 2017 Portfolio in Review
As of Q4 2017, Morgan Stanley held 6,934 positions worth $365B, up 9.4% from $334B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $13.3B of net new capital in Q4 2017, opening 268 new positions and adding to 3,628 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $1.45B trimmed.
- Morgan Stanley's largest Q4 2017 buy was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $4.24B increase.
- Morgan Stanley's biggest Q4 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.45B.
- Morgan Stanley fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $210M.
- Morgan Stanley's ten largest holdings make up 14% of its $365B portfolio in Q4 2017.
- Morgan Stanley opened 268 new positions and closed 177 in Q4 2017.
- Morgan Stanley's portfolio value rose 9.4% quarter-over-quarter to $365B.
Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.